Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030)
Clinical trial NCT01405924 · TERMINATED
Trial details
- NCT number
- NCT01405924
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-25
- Primary completion
- 2013-12-06
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.